• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Pre-Market Approval (PMA)

Orthofix wins FDA PMA for bone growth stimulation device

May 4, 2022 By Sean Whooley

Orthofix (Nasdaq:OFIX) announced today that it received FDA premarket approval (PMA) for its AccelStim bone healing therapy device. Lewisville, Texas-based Orthofix designed the AccelStim device to provide a safe and effective nonsurgical treatment for indicated fresh fractures and for fractures that have not healed (nonunions). According to a news release, the device generates a low-intensity […]

Filed Under: Featured, Food & Drug Administration (FDA), Implants, News Well, Orthopedics, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: FDA, Orthofix

FDA approves Transmedics OCS Heart organ transplant system

April 28, 2022 By Sean Whooley

TransMedics (Nasdaq:TMDX) announced today that it received FDA premarket approval (PMA) for its OCS Heart system. FDA PMA allows Andover, Massachusetts-based TransMedics to expand the pool of eligible heart donors in the U.S. to organs from donors after circulatory death (DCD). The company had previously received PMA for the OCS Heart system for use with […]

Filed Under: Cardiovascular, Clinical Trials, Featured, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance, Transplants Tagged With: FDA, transmedics

FDA approves GE Healthcare software that automates anesthesia, reduces greenhouse gas emissions during surgery

April 18, 2022 By Danielle Kirsh

GE Healthcare recently announced that it received FDA premarket approval for its End-tidal (Et) Control software for general anesthesia delivery. The software is approved for use with GE Healthcare’s Aisys CS2 anesthesia delivery system. The Chicago-based company initially released the technology in Europe in 2010 and is currently used in over 100 countries. Get the […]

Filed Under: Featured, Health Technology, News Well, Patient Monitoring, Pre-Market Approval (PMA), Regulatory/Compliance, Software / IT Tagged With: GE Healthcare

Bioventus plans to buy CartiHeal for at least $315M to launch knee implant

April 4, 2022 By Jim Hammerand

Bioventus (Nasdaq: BVS) today said it plans to buy CartiHeal following the FDA’s recent premarket approval of the Israel-based medtech developer’s Agili-C implant. Durham, North Carolina-based Bioventus will pay about $315 million to buy the company, excluding the stake already owned by Bioventus after it made a $50 million escrow payment last year. The deal also […]

Filed Under: Blog, Business/Financial News, Featured, Food & Drug Administration (FDA), Implants, Mergers & Acquisitions, News Well, Orthopedics, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: Bioventus, CartiHeal Ltd., FDA

FDA approves Abbott’s leadless pacemaker for patients with slow heart rhythms

April 4, 2022 By Sean Whooley

Abbott (NYSE:ABT) announced today that the FDA approved its Aveir single-chamber (VR) leadless pacemaker for slow heart rhythms. In November 2021, the Abbott Park, Illinois-based company reported results from an FDA investigational device exemption (IDE) study that showed that Aveir met pre-specified primary endpoints in patients with certain abnormal heart rhythms, suggesting that, if approved, […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Food & Drug Administration (FDA), Implants, News Well, Pre-Market Approval (PMA), Regulatory/Compliance, Structural Heart Tagged With: Abbott, FDA

CartiHeal wins FDA premarket approval for its Agili-C knee implant

March 30, 2022 By Sean Whooley

CartiHeal announced today that it received FDA premarket approval for its Agili-C implant for treating knee joint surface lesions. Kfar Saba, Israel-based CartiHeal designed its Agili-C implant as a proprietary implant for treating cartilage lesions in arthritic and non-arthritic joints. Its PMA indication covers the treatment of an International Cartilage Repair Society (ICRS) grade III […]

Filed Under: Featured, Food & Drug Administration (FDA), Implants, Orthopedics, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: CartiHeal Ltd., FDA

FDA approves expanded indication for Abbott’s CardioMEMS

February 22, 2022 By Chris Newmarker

The FDA has expanded the number of people who can use Abbott’s tiny implantable CardioMEMS heart failure sensor. The approval of the expanded indication, announced yesterday, means that an additional 1.2 million people in the U.S. with heart failure could take advantage of the Abbott system. The CardioMEMS HF system remotely monitors pulmonary artery (PA) […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Food & Drug Administration (FDA), News Well, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: Abbott, FDA

Medtronic wins FDA expanded approval to use cardiac cryoablation catheters in kids

February 18, 2022 By Danielle Kirsh

Medtronic today announced that it received FDA expanded approval for its Freezor and Freezor Xtra cardiac cryoablation catheters for pediatric atrioventricular nodal reentrant tachycardia (AVRNT). AVNRT is the most common form of supraventricular tachycardia and involves a life-threatening abnormal heart rhythm. More than a third of AVRNY cases are in pediatrics or children under the age […]

Filed Under: Cardiovascular, Catheters, Featured, Food & Drug Administration (FDA), News Well, Pre-Market Approval (PMA), Regulatory/Compliance, Structural Heart Tagged With: Medtronic

FDA approves Medtronic’s spinal cord stimulation for chronic pain from diabetic neuropathy

January 24, 2022 By Sean Whooley

Medtronic (NYSE:MDT) announced today the FDA approved its Intellis and Vanta neurostimulator for treating chronic pain. The approval covers the Intellis rechargeable neurostimulator and the Vanta recharge-free neurostimulator for the treatment of chronic pain associated with diabetic peripheral neuropathy. The new indication offers DPN patients access to Medtronic’s spinal cord stimulation (SCS) portfolio of both […]

Filed Under: Diabetes, Featured, Food & Drug Administration (FDA), Implants, Neurological, Neuromodulation/Neurostimulation, News Well, Pain Management, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: Medtronic

FDA approves expanded labeling for Nevro spinal cord stimulation

January 19, 2022 By Danielle Kirsh

Nevro (NYSE:NVRO) today said it received FDA approval for expanded labeling of its Senza spinal cord stimulations system to treat non-surgical refractory back pain (NSRBP). Redwood City, California–based Nevro designed the 10 kHz therapy to improve pain relief and reduce opioid use. The 12-month results from a study of the system showed that patients who […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Neuromodulation/Neurostimulation, News Well, Pain Management, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: Nevro Corp.

FDA approves Cochlear Nucleus Implant for unilateral hearing loss, single-sided deafness

January 11, 2022 By Danielle Kirsh

Cochlear Ltd. (ASX:COH) today announced that it received FDA approval for extended applications of its Nucleus implants. Sydney, Australia-based Cochlear designed the Nucleus implants to treat unilateral hearing loss (UHL) and single-sided deafness (SSD). The implants were already FDA approved for those with moderate to profound bilateral sensorineural hearing loss. UHL is characterized by hearing loss […]

Filed Under: Food & Drug Administration (FDA), Implants, Otolaryngology/Ear, Nose & Throat (ENT), Pre-Market Approval (PMA) Tagged With: cochlear

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 54
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS